Scotiabank upgraded shares of Healthpeak Properties (NYSE:DOC – Free Report) to a hold rating in a report published on Thursday,Zacks.com reports.
A number of other research firms have also recently commented on DOC. Argus cut Healthpeak Properties from a “buy” rating to a “hold” rating in a research report on Thursday, February 5th. Wells Fargo & Company restated a “positive” rating on shares of Healthpeak Properties in a research report on Tuesday, February 3rd. Weiss Ratings upgraded Healthpeak Properties from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Monday, January 26th. Evercore dropped their target price on Healthpeak Properties from $21.00 to $19.00 and set an “outperform” rating on the stock in a research report on Wednesday, February 4th. Finally, UBS Group initiated coverage on Healthpeak Properties in a research report on Monday, April 20th. They set a “neutral” rating and a $17.00 target price on the stock. Six research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $19.04.
View Our Latest Stock Report on DOC
Healthpeak Properties Price Performance
Healthpeak Properties (NYSE:DOC – Get Free Report) last announced its quarterly earnings results on Monday, February 2nd. The real estate investment trust reported $0.47 earnings per share for the quarter, topping the consensus estimate of $0.45 by $0.02. Healthpeak Properties had a return on equity of 0.84% and a net margin of 2.52%.The company had revenue of $719.40 million for the quarter, compared to the consensus estimate of $685.14 million. During the same period last year, the firm earned $0.46 EPS. The firm’s revenue for the quarter was up 3.1% compared to the same quarter last year. Healthpeak Properties has set its FY 2026 guidance at 1.700-1.740 EPS. Research analysts predict that Healthpeak Properties will post 1.74 earnings per share for the current year.
Healthpeak Properties Dividend Announcement
The business also recently declared a monthly dividend, which will be paid on Friday, June 26th. Investors of record on Monday, June 15th will be paid a $0.1017 dividend. The ex-dividend date of this dividend is Monday, June 15th. This represents a c) dividend on an annualized basis and a yield of 7.4%. Healthpeak Properties’s dividend payout ratio (DPR) is currently 1,220.00%.
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Argent Advisors Inc. lifted its stake in Healthpeak Properties by 5.4% in the 1st quarter. Argent Advisors Inc. now owns 76,153 shares of the real estate investment trust’s stock valued at $1,251,000 after buying an additional 3,922 shares in the last quarter. IFM Investors Pty Ltd lifted its stake in Healthpeak Properties by 1.4% in the 1st quarter. IFM Investors Pty Ltd now owns 258,497 shares of the real estate investment trust’s stock valued at $4,247,000 after buying an additional 3,544 shares in the last quarter. Rexford Capital Inc. lifted its stake in Healthpeak Properties by 125.0% in the 1st quarter. Rexford Capital Inc. now owns 3,600 shares of the real estate investment trust’s stock valued at $59,000 after buying an additional 2,000 shares in the last quarter. Inspire Investing LLC lifted its stake in Healthpeak Properties by 11.1% in the 1st quarter. Inspire Investing LLC now owns 22,647 shares of the real estate investment trust’s stock valued at $372,000 after buying an additional 2,265 shares in the last quarter. Finally, Intrua Financial LLC lifted its stake in Healthpeak Properties by 1.1% in the 1st quarter. Intrua Financial LLC now owns 66,702 shares of the real estate investment trust’s stock valued at $1,096,000 after buying an additional 744 shares in the last quarter. 93.57% of the stock is owned by hedge funds and other institutional investors.
Healthpeak Properties Company Profile
Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.
Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.
Featured Articles
Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.
